Cargando…

High-Dose Terazosin Therapy (5 mg) in Korean Patients with Lower Urinary Tract Symptoms with or without Concomitant Hypertension: A Prospective, Open-Label Study

PURPOSE: We determined the efficacy and safety of a relatively high dose of terazosin (5 mg) in Korean patients with lower urinary tract symptoms (LUTS), with or without concomitant hypertension. MATERIALS AND METHODS: From July to December 2006, 200 men who consecutively presented with LUTS were pr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kwak, Cheol, Lee, Jeong Ki, Ku, Ja Hyeon
Formato:	Texto
Lenguaje:	English
Publicado:	Yonsei University College of Medicine 2007
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2628180/ https://www.ncbi.nlm.nih.gov/pubmed/18159592 http://dx.doi.org/10.3349/ymj.2007.48.6.994

Ejemplares similares

Rate and association of lower urinary tract infection with recurrence after transurethral resection of bladder tumor
por: Kim, Byung Soo, et al.
Publicado: (2018)

Non-invasive Parameters Predicting Bladder Outlet Obstruction in Korean Men with Lower Urinary Tract Symptoms
por: Kang, Min-Yong, et al.
Publicado: (2010)

Impacts of the Quinazoline-Based Alpha1-Antagonist, Terazosin, and of the Sulfonamide Derivative, Tamsulosin, on Serum Prostate-Specific Antigen and Prostate Volume
por: Paick, Jae-Seung, et al.
Publicado: (2008)

AB083. Does concomitant testosterone replacement improve the response of tadalafil 5 mg once daily in men with lower urinary tract symptoms?
por: Park, Nam Cheol, et al.
Publicado: (2016)

Intraoperative floppy iris syndrome associated with terazosin
por: Venkatesh, Rengaraj, et al.
Publicado: (2007)

RE: Preoperative serum albumin as a prognostic factor in patients with upper urinary tract urothelial carcinoma
por: Ku, Ja Hyeon, et al.
Publicado: (2015)

Terazosin Stimulates Pgk1 to Remedy Gastrointestinal Disorders
por: Liu, Jingjing, et al.
Publicado: (2021)

Association between demographic factors and prognosis in urothelial carcinoma of the upper urinary tract: a systematic review and meta-analysis
por: Kim, Hyung Suk, et al.
Publicado: (2016)

Are urothelial carcinomas of the upper urinary tract a distinct entity from urothelial carcinomas of the urinary bladder? Behavior of urothelial carcinoma after radical surgery with respect to anatomical location: a case control study
por: Kim, Myong, et al.
Publicado: (2015)

Impact of Squamous and Glandular Differentiation on Oncologic Outcomes in Upper and Lower Tract Urothelial Carcinoma
por: Lee, Young Ju, et al.
Publicado: (2014)

Estimated Glomerular Filtration Rate as a Prognostic Factor in Urothelial Carcinoma of the Upper Urinary Tract: A Systematic Review and Meta-Analysis
por: Kim, Min Hyuk, et al.
Publicado: (2021)

Terazosin Treatment Induces Caspase-3 Expression in the Rat Ventral Prostate
por: Papadopoulos, Georgios, et al.
Publicado: (2013)

Transdermal iontophoresis delivery system for terazosin hydrochloride: an in vitro and in vivo study
por: Jiang, Changzhao, et al.
Publicado: (2021)

Cost-Effectiveness of Tamsulosin, Doxazosin, and Terazosin in the Treatment of Benign Prostatic Hyperplasia
por: Ohsfeldt, Robert L., et al.
Publicado: (2004)

Increased urinary B2-microglobulin is associated with poor prognosis of upper tract urothelial carcinoma
por: Han, Jang Hee, et al.
Publicado: (2022)

Molecular Regulation of Concomitant Lower Urinary Tract Symptoms and Erectile Dysfunction in Pelvic Ischemia
por: Tarcan, Tufan, et al.
Publicado: (2022)

Terazosin Analogs Targeting Pgk1 as Neuroprotective Agents: Design, Synthesis, and Evaluation
por: Wang, Yang, et al.
Publicado: (2022)

Optogenetic Modulation of Urinary Bladder Contraction for Lower Urinary Tract Dysfunction
por: Park, Jae Hong, et al.
Publicado: (2017)

Relationship between Lower Urinary Tract Symptoms/Benign Prostatic Hyperplasia and Metabolic Syndrome in Korean Men
por: Park, Yeon Won, et al.
Publicado: (2012)

The effectiveness of tamsulosin hydrochloride with terazosin combination therapy for chronic prostatitis Type-III b
por: Duan, Bin, et al.
Publicado: (2022)

Survival Outcomes and Predictive Factors for Female Urethral Cancer: Long-term Experience with Korean Patients
por: Kang, Minyong, et al.
Publicado: (2015)

Psychometric validation study of the Korean version of the Functional Assessment of Cancer Therapy-Vanderbilt Cystectomy Index
por: Kim, Myong, et al.
Publicado: (2018)

Effects of Obesity on Prostate Volume and Lower Urinary Tract Symptoms in Korean Men
por: Kim, Geun Woo, et al.
Publicado: (2010)

Sociodemographic Factors Related to Lower Urinary Tract Symptoms in Men: A Korean Community Health Survey
por: Jo, Jung Ki, et al.
Publicado: (2017)

The Efficacy and Safety of Tadalafil 5 mg Once Daily in Korean Men with Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia: An Integrated Analysis
por: Lee, Sung Won, et al.
Publicado: (2014)

The Characteristics of Recurrent Upper Tract Urothelial Carcinoma after Radical Nephroureterectomy without Bladder Cuff Excision
por: Kang, Minyong, et al.
Publicado: (2015)

Seasonal Variation of Urinary Symptoms in Korean Men with Lower Urinary Tract Symptoms and Benign Prostatic Hyperplasia
por: Choi, Ho Chul, et al.
Publicado: (2015)

Korean version of the convalescence and recovery evaluation: translation and linguistic validation
por: Yuk, Hyeong Dong, et al.
Publicado: (2020)

Sensitive Determination of Terazosin in Pharmaceutical Formulations and Biological Samples by Ionic-Liquid Microextraction Prior to Spectrofluorimetry
por: Zeeb, Mohsen, et al.
Publicado: (2012)

Stability-Indicating RP-HPLC Method for the Simultaneous Determination of Prazosin, Terazosin, and Doxazosin in Pharmaceutical Formulations
por: Shrivastava, Alankar, et al.
Publicado: (2012)

Do Lifestyle Factors Affect Lower Urinary Tract Symptoms? Results from the Korean Community Health Survey
por: Kim, Kyu Shik, et al.
Publicado: (2019)

Efficacy of neoadjuvant atezolizumab treatment in patients with advanced urothelial bladder cancer according to the BASQ classification: a study protocol for an open-label, two-cohort, phase II trial
por: Yuk, Hyeong Dong, et al.
Publicado: (2020)

The Potential Role of Urinary Microbiome in Benign Prostate Hyperplasia/Lower Urinary Tract Symptoms
por: Yu, Seong Hyeon, et al.
Publicado: (2022)

Efficacy of 0.4 mg tamsulosin monotherapy in patients with moderate-to-severe lower urinary tract symptoms
por: Kang, Tae Wook, et al.
Publicado: (2021)

Localized Resectable Genitourinary Sarcoma in Adult Korean Patients: Experiences at a Single Center
por: Cho, Sung Yong, et al.
Publicado: (2011)

24-Hour blood pressure response to lower dose (30 mg) fimasartan in Korean patients with mild to moderate essential hypertension
por: Lee, Hae-Young, et al.
Publicado: (2017)

Uroplakins in the Lower Urinary Tract
por: Lee, Gilho
Publicado: (2011)

Pharmacology of the lower urinary tract
por: Hennenberg, Martin, et al.
Publicado: (2014)

Lower Urinary Tract Neoplasia
por: Griffin, Maureen A., et al.
Publicado: (2018)

Targeted next-generation sequencing for locally advanced prostate cancer in the Korean population
por: Suh, Jungyo, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_83epjifl7ei2u9fv2cn6e87od1